Efeito de uma intervenção de controle nutricional móvel baseada em aplicação em todo o curso em pacientes com degeneração macular relacionada à idade: um ensaio controlado randomizado

O que aconteceu

Evaluate the effect of the application (APP)-based AIM-AMD (Assessment, Introduction, Management, and App-based Maintenance Dynamically) nutrition management model in patients with age-related macular degeneration (AMD). Nutritional intervention are one of the only ways to prevent the development of AMD and slow its progression. However, poor compliance with patient nutritional management leads to ineffective nutritional supplementation outcomes. A randomised controlled trial was conducted from October 2023-January 2024 and performed according to the CONSORT guidelines. A total of 140 participants were randomly assigned to the intervention or control group. The intervention was administered three times per week for a period of 3 months. The intervention group was adopted with APP-based AIM-AMD nutrition management + routine nursing, while the control group was adopted with routine nursing. Comparison was conducted on the effects of different programs on AMD patient nutrient intake, nutrition knowledge, vision-related quality of life, self-efficacy and best-corrected visual acuity (BCVA) at the beginning and at the end of the intervention (Clinical Trials.gov: ChiCTR2200063978). https://www.chictr.org.cn/showproj.html?proj=175931, Identifier ChiCTR2200063978.

Trecho mantido em inglês: a tradução automática não passou na conferência de números.

O que encontraram

Os resultados indicaram que a ingestão de energia, zinco, cobre, cálcio, vitamina C, vitamina E e luteína foi significativamente maior no grupo intervenção do que no grupo controle (p 0,05).

Por que isso importa

Nossa pesquisa demonstra que o modelo de gestão nutricional AIM-AMD baseado em APP oferece aos pacientes orientações abrangentes, precisas e personalizadas sobre a gestão alimentar. Os resultados deste estudo demonstram que o modelo de manejo nutricional da AIM-AMD possui valor clínico demonstrável no processo de manejo nutricional de pacientes com DMA.